Ledger.Open graph →
SEC Form D · filed July 11, 2014

Sprout Pharmaceuticals, Inc

Offering
$15.0M
Sold
$4.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Robert J. Creaney · WEST CONSHOHOCKEN, PAExec · DirectorMatthew J. Graver · WEST CONSHOHOCKEN, PAExecDavid A. Wilton · WEST CONSHOHOCKEN, PADirectorDebbra L. Schoneman · Minneapolis, MNExecNeha D. Markle · WEST CONSHOHOCKEN, PAExec · DirectorSteven A. Shin · WEST CONSHOHOCKEN, PAExec · DirectorTimothy J. Knierim · WEST CONSHOHOCKEN, PAExecVictoria A. Eckstein · WEST CONSHOHOCKEN, PAExec · DirectorEdward J. Goldstein · WEST CONSHOHOCKEN, PAExec · DirectorSheri L. Schreck · WEST CONSHOHOCKEN, PAExecMelissa J. Kang · WEST CONSHOHOCKEN, PADirectorPatrick A. Reid · WEST CONSHOHOCKEN, PADirectorAndrew J. Murray · WEST CONSHOHOCKEN, PADirectorDima E. Skvortsov · WEST CONSHOHOCKEN, PADirectorRyan A. Meredith · WEST CONSHOHOCKEN, PAExec · DirectorRobert W. Dahl · Raleigh, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗